KLOW Blend 20mg — Vial Spec, Reconstitution Math & COA
The 20mg KLOW blend vial is a specialized research compound combining four distinct peptides—BPC-157, TB-500, GHK-Cu, and KPV—designed for high-precision in vitro and animal model investigations into tissue matrix remodelling and inflammatory signaling. This reference guide provides principal investigators with technical specifications, exact liquid volume reconstitution calculations, aliquot preservation protocols, and analytical quality standards. PX1 Research supplies fully validated research peptides backed by lot-specific certificates of analysis to ensure reproducible laboratory outcomes.
Quick answer
The 20mg KLOW blend vial is a specialized research compound combining four distinct peptides—BPC-157, TB-500, GHK-Cu, and KPV—designed for high-precision in vitro and animal model investigations into tissue matrix remodelling and inflammatory signaling. This reference guide provides principal investigators with technical specifications, exact liquid volume reconstitution calculations, aliquot preservation protocols, and analytical quality standards. PX1 Research supplies fully validated research peptides backed by lot-specific certificates of analysis to ensure reproducible laboratory outcomes.
Key takeaways
- The KLOW blend represents a multi-target peptide matrix combining four widely studied research molecules: [BPC-157](/research-peptides/bpc-157) (Body Protection Compound 157), [TB-500](/research-peptides/tb-500) (Thymosin Beta-4 synthetic fragment), [GHK-Cu](/research-peptides/ghk-cu) (Copper Tripeptide-1), and KPV (Lysine-Proline-Valine tripeptide).
- To properly design laboratory protocols using the klow blend 20mg unit, investigators must account for the distinct biochemical targets and molecular weights of each constituent peptide.
- Calculating accurate working concentrations for a 20mg aggregate mass vial requires careful volume planning based on total peptide mass.
- Maintaining chemical stability and preventing aggregate formation during fluid addition requires strict adherence to aseptic reconstitution technique.
Overview of KLOW Blend 20mg Specifications and Inventory Availability
The KLOW blend represents a multi-target peptide matrix combining four widely studied research molecules: BPC-157 (Body Protection Compound 157), TB-500 (Thymosin Beta-4 synthetic fragment), GHK-Cu (Copper Tripeptide-1), and KPV (Lysine-Proline-Valine tripeptide). In a 20mg aggregate mass vial, these four constituents are lyophilized together in precise stoichiometric ratios to allow researchers to study multi-pathway cellular responses, extracellular matrix dynamics, and localized inflammatory cascades simultaneously within a single assay environment.
Principal investigators frequently utilize the 20mg vial format for short-duration pilot studies, acute micro-dose cell culture assays, or small-cohort rodent experiments where preserving working solution freshness takes precedence over high-volume capacity. Please note that while customized 20mg allocations are engineered for specialized assay runs, PX1 Research currently stocks the standardized KLOW Blend 80mg vial as our primary catalog offering to provide superior cost-per-milligram efficiency and extended lot continuity for large-scale longitudinal trials. Researchers seeking alternative unit sizes or individual constituent peptides can review our complete selection via /all-peptides.
Constituent Peptide Mechanisms and Synergistic Preclinical Assays
To properly design laboratory protocols using the klow blend 20mg unit, investigators must account for the distinct biochemical targets and molecular weights of each constituent peptide. Preclinical studies suggest that combining these four entities creates a comprehensive model for investigating cellular migration, angiogenesis, gene transcription, and cytokine modulation in tissue culture and animal models.
BPC-157 is a 15-amino-acid pentadecapeptide investigated in animal models for its role in upregulating vascular endothelial growth factor (VEGF) receptor expression and activating the FAK-paxillin signaling pathway. TB-500, an active domain fragment of Thymosin Beta-4, acts primarily through actin sequestration, promoting cell motility, cell proliferation, and microvascular sprouting in endothelial cell lines. GHK-Cu is a naturally occurring copper complex that, in vitro, has been shown to modulate collagen synthesis, stimulate glycosaminoglycan production, and regulate matrix metalloproteinase (MMP) transcription. Finally, KPV—an alpha-MSH derivative—exhibits anti-inflammatory signaling in preclinical models by inhibiting NF-kB nuclear translocation and suppressing pro-inflammatory cytokine secretion. Together, this quadrupartite matrix allows researchers to evaluate overlapping biological repair cascades.
Reconstitution Mathematics for 20mg Lyophilized Vials
Calculating accurate working concentrations for a 20mg aggregate mass vial requires careful volume planning based on total peptide mass. When reconstituting 20mg of total lyophilized powder, the resulting concentration per milliliter is inversely proportional to the volume of sterile diluent added. Researchers can perform precise volumetric calculations using our interactive /reconstitution-calculator or apply the standardized math outlined below.
Adding 1.0 mL of diluent (such as bacteriostatic water or 0.9% sterile saline) to a 20mg vial yields a high-density working stock solution of 20.0 mg/mL (or 20.0 µg per microliter). Adding 2.0 mL of diluent yields a concentration of 10.0 mg/mL (10.0 µg/µL). Adding 3.0 mL of diluent results in a concentration of approximately 6.67 mg/mL (6.67 µg/µL). If the four constituent peptides are present in equal 5mg proportions within the 20mg total mass, a 2.0 mL total reconstitution volume produces individual peptide concentrations of 2.5 mg/mL (2.5 µg/µL) per compound, facilitating straightforward micro-pipetting into cell culture media or micro-dosing delivery systems.
Step-by-Step Laboratory Reconstitution Protocol
Maintaining chemical stability and preventing aggregate formation during fluid addition requires strict adherence to aseptic reconstitution technique. Before initiating liquid transfer, ensure all work surfaces are sanitized within a certified laminar flow hood, and wipe the rubber septum of the vial with 70% isopropyl alcohol.
Using a sterile syringe, draw the predetermined volume of diluent (e.g., bacteriostatic water containing 0.9% benzyl alcohol). Invert the vial at a 45-degree angle and slowly direct the stream of fluid down the glass wall rather than spraying directly onto the lyophilized cake. Allow the vacuum to gently draw the liquid into the vial; do not force liquid under excess manual pressure. Once the diluent is introduced, gently swirl the vial in a circular motion on the benchtop until the cake completely dissolves into a clear, colorless liquid. Never shake or vortex the reconstituted klow blend 20mg vial, as high mechanical shear stress can denature delicate peptide chains and induce irreversible protein aggregation.
Aliquot Planning and Solution Stability in Micro-Centrifuge Tubes
Repeated freeze-thaw cycles significantly accelerate peptide degradation via peptide bond hydrolysis and conformational changes. To preserve chemical integrity over extended experimental timelines, laboratory protocols should incorporate an immediate post-reconstitution aliquoting step.
Divide the reconstituted stock solution into single-use micro-centrifuge tubes or low-protein-binding cryo-vials based on the daily volume required for your assays. For instance, if an assay requires 100 µL per trial day, split a 2.0 mL reconstituted volume into twenty 100 µL sterile aliquots. Store working aliquots designated for immediate use within 48 to 72 hours in a standard laboratory refrigerator at 2°C to 8°C. Long-term storage of working stock should be maintained in a manual defrost deep freezer at -20°C to -80°C. Shield all aliquots containing GHK-Cu from direct ultraviolet light exposure, as copper complexes exhibit light-sensitive oxidation patterns over time.
Comparative Analysis: Selecting 20mg vs. High-Mass Multi-Dosage Formats
Choosing between a 20mg vial configuration and higher-mass formats like the 80mg variant depends largely on your laboratory's throughput, budget, and experimental window. Small 20mg vials minimize waste when testing short-term in vitro assays where solution stability degrades before a larger vial can be depleted.
However, for high-frequency animal studies, multi-well cell screening, or longitudinal protocols spanning several weeks, higher-capacity options like our KLOW Blend 80mg offer distinct analytical advantages. Utilizing an 80mg vial reduces batch-to-batch variability by allowing researchers to maintain a single reconstituted stock throughout an entire trial phase. Furthermore, high-volume research facilities ordering for extended projects can utilize our /wholesale portal to secure bulk quantity allocations with unified lot verification.
Analytical Verification: Lot-Specific HPLC, MS, and Endotoxin Testing
In modern preclinical research, compound purity directly impacts experimental reproducibility. Impurities such as truncated peptide fragments, residual TFA (trifluoroacetic acid), or bacterial endotoxins can confound cell culture viability assays and induce non-specific immune responses in animal models. PX1 Research subjects every synthesis batch to rigorous analytical testing in ISO 17025 accredited facilities.
Each batch of the klow blend 20mg format undergoes High-Performance Liquid Chromatography (HPLC) to confirm overall chemical purity (>99.0%), Mass Spectrometry (MS) to verify precise molecular weights of all four component peptides, and Chromogenic LAL assays to ensure endotoxin levels remain strictly below standard safety thresholds (<0.01 EU/mg). Principal investigators can review complete batch documentation, spectrum charts, and verification seals prior to purchasing by visiting our public analytical portal at /coa.
Comparative Evaluation of Synergistic Tissue Repair and Cytokine Modulating Blends
When evaluating matrix repair and anti-inflammatory candidates for laboratory research, investigators frequently compare multi-component blends with single-entity peptide isolates to determine the optimal experimental control.
For example, researchers studying localized tissue remodeling may evaluate individual isolates such as standalone BPC-157 or TB-500 to establish single-target baseline pathways before introducing composite matrices. Conversely, protocols targeted specifically at anti-inflammatory cellular cascades might isolate KPV to measure NF-kB pathway inhibition without the confounding anabolic signaling associated with copper tripeptides. Comparing multi-target formulations against single-peptide isolates allows research teams to map distinct synergistic mechanisms within tissue culture models.
Storage Standards and Lyophilized Cake Stability Metrics
Unreconstituted lyophilized peptide cakes display high thermodynamic stability when maintained under controlled ambient and sub-zero environmental conditions. Upon receipt from PX1 Research, dry vials should be stored immediately in a desiccated environment at -20°C for short-to-medium term storage, or -80°C for multi-year preservation.
All PX1 orders ship directly from specialized, climate-controlled dispatch facilities located in California and Arizona. Packages are processed with same-day shipping (Monday through Friday) to ensure minimal ambient exposure during transport. When properly stored in a sub-zero freezer away from moisture and light, lyophilized klow blend 20mg vials maintain guaranteed chemical stability and purity standards for up to 24 months from the date of manufacture. To explore detailed storage guidelines, mechanism papers, and experimental designs, visit our central scientific repository at /research.
Frequently Asked Questions
What is contained inside a KLOW Blend 20mg vial?
A 20mg KLOW blend vial contains a total aggregate mass of 20 milligrams of lyophilized peptide powder, composed of four distinct research compounds: BPC-157, TB-500, GHK-Cu, and KPV, formulated for laboratory in vitro and preclinical research.
Does PX1 Research currently stock the 20mg KLOW Blend size?
PX1 Research primarily stocks the high-yield KLOW Blend 80mg vial in our standard catalog to optimize lot continuity and cost efficiency for extended research protocols. Custom 20mg configurations are prepared for specific high-throughput laboratory orders.
How do I calculate the liquid concentration when reconstituting a 20mg vial?
Divide the total peptide mass (20mg) by the volume of diluent added in milliliters. Adding 1mL diluent yields 20mg/mL (20µg/µL); adding 2mL yields 10mg/mL (10µg/µL); adding 3mL yields approximately 6.67mg/mL (6.67µg/µL).
What diluent is recommended for reconstituting the KLOW blend for lab use?
Bacteriostatic water (0.9% benzyl alcohol) is recommended for multi-dose laboratory assays requiring solution preservation over several days. Sterile 0.9% sodium chloride (saline) may also be used for immediate single-day experimental applications.
How should reconstituted KLOW blend working solutions be stored?
Reconstituted solutions should be aliquoted into single-use micro-centrifuge tubes and stored at 2°C to 8°C for short-term use (up to 72 hours) or frozen at -20°C to -80°C for extended storage. Protect solutions from direct light.
Where can I access the Certificate of Analysis (COA) for my lot?
Lot-matched Certificates of Analysis displaying HPLC purity profiles, mass spectrometry verification, and endotoxin test results are accessible online through our dedicated portal at /coa.
What are the primary research targets of the four constituent peptides?
In preclinical research, BPC-157 and TB-500 are studied for cell migration and angiogenic signaling, GHK-Cu for extracellular matrix protein synthesis, and KPV for anti-inflammatory cytokine modulation via NF-kB suppression.
Can KLOW blend 20mg be used for human or veterinary administration?
No. All products supplied by PX1 Research are strictly for laboratory research use, in vitro assays, and preclinical animal investigation. They are strictly not for human, clinical, or veterinary consumption.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.